{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:29:21Z","timestamp":1788866961564,"version":"build-2803163510"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.14321","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T15:35:00Z","timestamp":1654011300000},"page":"e2214321","source":"Crossref","is-referenced-by-count":9,"title":["Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants"],"prefix":"10.1001","volume":"5","author":[{"given":"Sean D.","family":"Pokorney","sequence":"first","affiliation":[{"name":"Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Cocoros","sequence":"additional","affiliation":[{"name":"Harvard Pilgrim Health Care Institute, Harvard Medical School Department of Population Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein R.","family":"Al-Khalidi","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Haynes","sequence":"additional","affiliation":[{"name":"HealthCore Inc, Alexandria, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana M.","family":"Al-Khatib","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Corrigan-Curay","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meighan Rogers","family":"Driscoll","sequence":"additional","affiliation":[{"name":"Harvard Pilgrim Health Care Institute, Harvard Medical School Department of Population Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Garcia","sequence":"additional","affiliation":[{"name":"Harvard Pilgrim Health Care Institute, Harvard Medical School Department of Population Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara B.","family":"Calvert","sequence":"additional","affiliation":[{"name":"Clinical Trials Transformation Initiative, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Harkins","sequence":"additional","affiliation":[{"name":"Humana Healthcare Research Inc, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jin","sequence":"additional","affiliation":[{"name":"Harvard Pilgrim Health Care Institute, Harvard Medical School Department of Population Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Knecht","sequence":"additional","affiliation":[{"name":"Aetna Inc, Blue Bell, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Levenson","sequence":"additional","affiliation":[{"name":"Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D.","family":"Lin","sequence":"additional","affiliation":[{"name":"OptumInsight Life Sciences Inc, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Martin","sequence":"additional","affiliation":[{"name":"Moderna Inc, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbe","family":"McCall","sequence":"additional","affiliation":[{"name":"Rowan Tree Perspectives Consulting, Murrieta, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"McMahill-Walraven","sequence":"additional","affiliation":[{"name":"Aetna Inc, Blue Bell, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinit","family":"Nair","sequence":"additional","affiliation":[{"name":"Humana Healthcare Research Inc, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Parlett","sequence":"additional","affiliation":[{"name":"HealthCore Inc, Alexandria, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Petrone","sequence":"additional","affiliation":[{"name":"Harvard Pilgrim Health Care Institute, Harvard Medical School Department of Population Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Temple","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongmei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Humana Healthcare Research Inc, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Platt","sequence":"additional","affiliation":[{"name":"Harvard Pilgrim Health Care Institute, Harvard Medical School Department of Population Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"issue":"2","key":"zoi220422r1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jacc.2010.10.001","article-title":"2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"57","author":"Wann","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"zoi220422r2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"zoi220422r3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","article-title":"Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study.","volume":"147","author":"Wolf","year":"1987","journal-title":"Arch Intern Med"},{"issue":"8532","key":"zoi220422r4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0140-6736(87)90174-7","article-title":"Risk of stroke in non-rheumatic atrial fibrillation.","volume":"1","author":"Flegel","year":"1987","journal-title":"Lancet"},{"issue":"7","key":"zoi220422r5","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1161\/STROKEAHA.109.549428","article-title":"Current status of stroke risk stratification in patients with atrial fibrillation.","volume":"40","author":"Hart","year":"2009","journal-title":"Stroke"},{"issue":"10","key":"zoi220422r6","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation: the Framingham Study.","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"issue":"9","key":"zoi220422r7","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study.","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"zoi220422r8","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association.","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"issue":"12","key":"zoi220422r9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9921","key":"zoi220422r10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"zoi220422r11","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS Focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons.","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"zoi220422r12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"zoi220422r13","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1161\/01.STR.0000208294.46968.a4","article-title":"Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation.","volume":"37","author":"Birman-Deych","year":"2006","journal-title":"Stroke"},{"issue":"1","key":"zoi220422r14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1001\/jamacardio.2015.0374","article-title":"Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk: insights from the NCDR PINNACLE Registry.","volume":"1","author":"Hsu","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"15","key":"zoi220422r15","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.113.005451","article-title":"Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY atrial fibrillation registry.","volume":"129","author":"Oldgren","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"zoi220422r16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ahj.2014.09.014","article-title":"Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke.","volume":"169","author":"Navar-Boggan","year":"2015","journal-title":"Am Heart J"},{"issue":"10","key":"zoi220422r17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jama.2017.1371","article-title":"Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation.","volume":"317","author":"Xian","year":"2017","journal-title":"JAMA"},{"issue":"20","key":"zoi220422r18","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.jacc.2017.03.540","article-title":"Influence of direct oral anticoagulants on rates of oral anticoagulation for atrial fibrillation.","volume":"69","author":"Marzec","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"7323","key":"zoi220422r19","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1136\/bmj.323.7323.1218","article-title":"Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study.","volume":"323","author":"Devereaux","year":"2001","journal-title":"BMJ"},{"key":"zoi220422r20","doi-asserted-by":"crossref","DOI":"10.1161\/circ.134.suppl_1.12882","article-title":"Provider rather than patient misperceptions appear to be the most common barriers to oral anticoagulation use for stroke prevention in atrial fibrillation.","volume":"134","author":"Pokorney","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"zoi220422r21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/archinternmed.2007.132","article-title":"A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction.","volume":"168","author":"Smith","year":"2008","journal-title":"Arch Intern Med"},{"key":"zoi220422r22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ahj.2020.07.012","article-title":"Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: a population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib).","volume":"229","author":"Al-Khatib","year":"2020","journal-title":"Am Heart J"},{"issue":"12","key":"zoi220422r24","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1161\/CIRCULATIONAHA.118.035909","article-title":"Adherence to guideline-directed stroke prevention therapy for atrial fibrillation is achievable.","volume":"139","author":"Piccini","year":"2019","journal-title":"Circulation"},{"issue":"10104","key":"zoi220422r25","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S0140-6736(17)32165-7","article-title":"A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial.","volume":"390","author":"Vinereanu","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"zoi220422r26","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1161\/CIR.0000000000000481","article-title":"ACC\/AHA special report: clinical practice guideline implementation strategies: a summary of systematic reviews by the NHLBI Implementation Science Work Group: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"135","author":"Chan","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"zoi220422r27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1055\/s-0038-1676835","article-title":"Improving the prescription of oral anticoagulants in atrial fibrillation: a systematic review.","volume":"119","author":"Pritchett","year":"2019","journal-title":"Thromb Haemost"},{"issue":"4","key":"zoi220422r28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/hast.v49.4","article-title":"Bystander ethics and good Samaritanism: a paradox for learning health organizations.","volume":"49","author":"Sabin","year":"2019","journal-title":"Hastings Cent Rep"},{"key":"zoi220422r29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.puhe.2016.03.030","article-title":"Why is changing health-related behaviour so difficult?","volume":"136","author":"Kelly","year":"2016","journal-title":"Public Health"},{"issue":"1","key":"zoi220422r30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40256-019-00356-2","article-title":"Educational impact on apixaban adherence in atrial fibrillation (the AEGEAN STUDY): a randomized clinical trial.","volume":"20","author":"Montalescot","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"zoi220422r31","doi-asserted-by":"publisher","DOI":"10.3310\/hta11050","article-title":"A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines.","volume":"11","author":"Raynor","year":"2007","journal-title":"Health Technol Assess"},{"issue":"12","key":"zoi220422r32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.40071","article-title":"The effects of implementing a mobile health\u2013technology supported pathway on atrial fibrillation\u2013related adverse events among patients with multimorbidity: the mAFA-II randomized clinical trial.","volume":"4","author":"Yao","year":"2021","journal-title":"JAMA Netw Open"},{"key":"zoi220422r33","doi-asserted-by":"publisher","journal-title":"J Am Coll Cardiol","DOI":"10.1016\/j.jacc.2020.01.052"},{"issue":"12","key":"zoi220422r34","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s11606-018-4612-6","article-title":"Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial.","volume":"33","author":"Ashburner","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi220422r35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/1740774520928426","article-title":"Practical challenges in the conduct of pragmatic trials embedded in health plans: lessons of IMPACT-AFib, an FDA-Catalyst trial.","volume":"17","author":"Garcia","year":"2020","journal-title":"Clin Trials"},{"issue":"1","key":"zoi220422r36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/1740774518812776","article-title":"FDA-Catalyst\u2014using FDA\u2019s Sentinel Initiative for large-scale pragmatic randomized trials: approach and lessons learned during the planning phase of the first trial.","volume":"16","author":"Cocoros","year":"2019","journal-title":"Clin Trials"},{"issue":"1","key":"zoi220422r37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/CIRCOUTCOMES.113.000371","article-title":"Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation.","volume":"8","author":"Thigpen","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"zoi220422r23","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to Meta-analysis","author":"Borenstein","year":"2009"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2792820\/pokorney_2022_oi_220422_1653320685.48442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T05:08:13Z","timestamp":1727327293000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2792820"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.14321","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]}}}